Shares of Axcella Health Inc. (NASDAQ:AXLA – Get Rating) have been assigned an average rating of “Buy” from the eight analysts that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the […]
Axcella Health (NASDAQ:AXLA – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, Zacks.com reports. The brokerage currently has a $2.75 price target on the stock. Zacks Investment Research‘s price target would suggest a potential upside of 5.77% from […]
Axcella Health Inc. (NASDAQ:AXLA – Get Rating) – Equities research analysts at SVB Leerink issued their Q1 2022 earnings estimates for Axcella Health in a research report issued on Wednesday, March 30th. SVB Leerink analyst T. Smith anticipates that the company will post earnings of ($0.42) per share for the quarter. SVB Leerink currently has […]
Axcella Health Inc. (NASDAQ:AXLA – Get Rating) CEO William Hinshaw purchased 13,089 shares of Axcella Health stock in a transaction dated Wednesday, March 16th. The stock was bought at an average price of $1.91 per share, with a total value of $24,999.99. The acquisition was disclosed in a document filed with the Securities & Exchange […]
Axcella Health Inc. (NASDAQ:AXLA – Get Rating) CFO Robert Crane bought 39,267 shares of the business’s stock in a transaction on Wednesday, March 16th. The shares were acquired at an average cost of $1.91 per share, for a total transaction of $74,999.97. The purchase was disclosed in a document filed with the SEC, which can […]